NIH Launches 2009 H1N1 Swine Flu Influenza Vaccine Trials in HIV-Infected Pregnant Women, HIV-Infected Children, and HIV-Infected Youth!

Swine Flu H1N1 Influenza Vaccine Trials have begun. The National Institutes of Health (NIH) launched the first clinical trials, to test whether the 2009 H1N1 Swine Flu influenza vaccine can safely elicit a protective immune response, in three HIV-infected populations—children, youth and pregnant women.

The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, both part of NIH.

“These studies are important because HIV infection and pregnancy both increase the risk for a poor immune response to the normal 15-microgram dose of seasonal influenza vaccine given to the general population,” says NIAID Director Anthony S. Fauci, M.D.

“Moreover, children, young people and pregnant women are at higher risk for . . .

Read the rest of this entry »

Tweet This Post